Medtronic Issues Communication about the Potential for Reduced Battery Performance in a Small Percentage of SynchroMed II Implantable Drug Infusion Pumps

Medtronic, Inc. MDT is issuing an urgent Medical Device Correction to provide physicians with additional information about the potential for reduced battery performance in a small percentage of its SynchroMed® II Implantable Drug Infusion Pumps. Medtronic first communicated about this issue in a July 2009 letter to physicians. This issue does not involve Medtronic external insulin pumps for diabetes. Medtronic is not retrieving the product from the field or recommending surgical removal of the devices unless a patient's pump demonstrates reduced battery performance.